Lyophilised (freeze-dried) and liquid peptide offerings can share a name on a product card and still differ in testing scope, storage expectations, and what a COA covers. Format choice should follow the documentation for the exact SKU — not assumptions about which container looks more “premium.”
Lyophilised materials
Lyophilised vials are commonly offered as dry cakes or powders with a labelled peptide amount. Documentation should still identify the lot, the molecule, and the analytical methods. Dry goods are often discussed in terms of stability before reconstitution in laboratory workflows — always follow your institution’s SOPs and the storage statements on the label and COA.
Liquid presentations
Liquid listings may describe concentration, solvent system, and fill volume. A COA written for a dry intermediate is not automatically evidence for a finished liquid lot. Confirm that testing covers the format you receive, and that storage conditions on the paperwork match how the item will be handled in transit and on arrival.
Comparison points that matter
- Does the COA describe the finished format on offer?
- Are labelled amounts and concentrations unambiguous?
- Are storage and expiry statements present for the sealed item?
- Is dispatch packaging appropriate for the stated storage needs?
If you are comparing two Apexyn listings with the same research compound in different presentations, treat each as its own SKU with its own batch paperwork.